These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20442584)

  • 1. Serum vascular endothelial growth factor and adiponectin levels in patients with benign and malignant gynecological diseases.
    Lasalandra C; Coviello M; Falco G; Divella R; Trojano G; Laterza AM; Quero C; Pepe V; Zito FA; Quaranta M
    Int J Gynecol Cancer; 2010 May; 20(4):507-12. PubMed ID: 20442584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F; Moreira de Andrade J; Bighetti S
    Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vascular endothelial growth factors a, C and d in human breast tumors.
    Gisterek I; Matkowski R; Lacko A; Sedlaczek P; Szewczyk K; Biecek P; Halon A; Staszek U; Szelachowska J; Pudelko M; Bebenek M; Harlozinska-Szmyrka A; Kornafel J
    Pathol Oncol Res; 2010 Sep; 16(3):337-44. PubMed ID: 19821158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
    Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
    Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
    Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast.
    Shivakumar S; Prabhakar BT; Jayashree K; Rajan MG; Salimath BP
    J Cancer Res Clin Oncol; 2009 Apr; 135(4):627-36. PubMed ID: 18936974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic values of vascular endothelial growth factor and epidermal growth factor receptor for benign and malignant hydrothorax.
    Gu Y; Zhang M; Li GH; Gao JZ; Guo L; Qiao XJ; Wang LH; He L; Wang ML; Yan L; Fu XH
    Chin Med J (Engl); 2015 Feb; 128(3):305-9. PubMed ID: 25635424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of VEGF and VEGF receptor concentrations in patients with benign and malignant thyroid tumors].
    Hedayati M; Kołomecki K; Pasieka Z; Korzeniowska M; Kuzdak K
    Endokrynol Pol; 2005; 56(3):252-8. PubMed ID: 16350718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions.
    Abdel-Razik A; ElMahdy Y; Hanafy EE; Elhelaly R; Elzehery R; M Tawfik A; Eldars W
    Am J Med Sci; 2016 Mar; 351(3):259-64. PubMed ID: 26992254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of determining the serum concentrations of vascular endothelial growth factor (VEGF) and its soluble receptor type 2 (sVEGF-2) in the differential diagnosis of adrenal incidentalomas.
    Foltyn W; Strzelczyk J; Marek B; Kajdaniuk D; Siemińska L; Rosiek V; Kos-Kudła B
    Endokrynol Pol; 2012; 63(1):22-8. PubMed ID: 22378094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
    Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
    J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of vascular endothelial growth factor in malignant ascites.
    Zhan N; Dong WG; Wang J
    Tumour Biol; 2016 Mar; 37(3):3719-25. PubMed ID: 26462841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites.
    Abdel-Razik A; Mousa N; Elalfy H; Sheta TF; Awad M; Abdelsalam M; Elhelaly R; Elzehery R; Gouda NS; Eldars W
    J Gastrointest Cancer; 2017 Mar; 48(1):50-57. PubMed ID: 27614744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of circulating endothelial progenitor cells and related angiogenic markers as prognostic factors in soft-tissue tumors.
    Karampinis I; Joas E; Dreyer A; Ronellenfitsch U; Jakob J; Hohenberger P; Nowak K
    Eur J Surg Oncol; 2018 Apr; 44(4):496-501. PubMed ID: 29397265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.